HBK Investments’s Assembly Biosciences ASMB Stock Holding History

HBK Investments’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,158	Closed	-$314K	–	1053
2018 Q4	$314K	Sell	1,158 -497	-30%	-$144K	﹤0.01%	1023
2018 Q3	$738K	Buy	+1,655	New	+$775K	0.01%	825

Other funds holding ASMB

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments's ASMB Position: Q1 2019 in Review

HBK Investments sold out of Assembly Biosciences (ASMB) in Q1 2019, closing a stake of 1,158 shares — an estimated $314K sold.

HBK Investments first reported a position in ASMB in Q3 2018 and held it in 2 quarters. The position peaked at $738K in Q3 2018. 103 funds tracked by Wall St. Rank hold ASMB as of Q1 2019.

HBK Investments reported no remaining Assembly Biosciences position as of Q1 2019 after selling out during the quarter.
HBK Investments sold 1,158 Assembly Biosciences shares in Q1 2019, an estimated $314K.
HBK Investments first reported a position in Assembly Biosciences in Q3 2018 and held it in 2 quarters.
HBK Investments's Assembly Biosciences position peaked at $738K in Q3 2018.
103 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.